Phenotyping Genetic Risk for Type 2 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 17, 2019

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Diabetes Mellitus, Type 2Genetics
Interventions
OTHER

75g glucose beverage (Glucola, Trutol, or similar brand)

Subjects will present fasting to the study day and ingest the glucose beverage during the oral glucose tolerance test.

OTHER

DXA, whole body

Subjects will undergo a whole body DXA scan for assessment of adiposity index and body fat distribution.

Trial Locations (2)

19104

NOT_YET_RECRUITING

Childrens Hospital of Philadelphia, Philadelphia

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER